Rodger Novak is President of CRISPR Therapeutics AG. Currently has a direct ownership of 573,007 shares of CRSP, which is worth approximately $25.9 Million. The most recent transaction as insider was on Mar 01, 2019, when has been sold 8,693 shares (Common Shares) at a price of $40.01 per share, resulting in proceeds of $347,807. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K
0% 3M change
0% 12M change
Total Value Held $25.9 Million

Rodger Novak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2019
SELL
Open market or private sale
$347,807 $40.01 p/Share
8,693 Reduced 0.84%
1,024,534 Common Shares
Feb 25 2019
SELL
Open market or private sale
$591,200 $40.0 p/Share
14,780 Reduced 1.41%
1,033,227 Common Shares
Jan 09 2019
SELL
Open market or private sale
$2,894,977 $35.01 p/Share
82,690 Reduced 7.31%
1,048,007 Common Shares
Jan 08 2019
SELL
Open market or private sale
$607,408 $35.09 p/Share
17,310 Reduced 1.51%
1,130,697 Common Shares
May 17 2018
SELL
Open market or private sale
$4,500,000 $60.0 p/Share
75,000 Reduced 6.13%
1,148,007 Common Shares
May 17 2018
BUY
Exercise of conversion of derivative security
$593,250 $7.91 p/Share
75,000 Added 5.78%
1,223,007 Common Shares
Sep 05 2017
SELL
Open market or private sale
$78,331 $20.33 p/Share
3,853 Reduced 0.33%
1,148,007 Common Shares
Sep 05 2017
BUY
Exercise of conversion of derivative security
$6,974 $1.81 p/Share
3,853 Added 0.33%
1,151,860 Common Shares
Aug 31 2017
SELL
Open market or private sale
$305,057 $20.87 p/Share
14,617 Reduced 1.26%
1,148,007 Common Shares
Aug 30 2017
SELL
Open market or private sale
$1,180,072 $20.31 p/Share
58,103 Reduced 4.76%
1,162,624 Common Shares
Aug 30 2017
BUY
Exercise of conversion of derivative security
$10,357 $1.81 p/Share
5,722 Added 0.47%
1,220,727 Common Shares
Aug 28 2017
SELL
Open market or private sale
$354,902 $20.06 p/Share
17,692 Reduced 1.44%
1,215,005 Common Shares
Aug 28 2017
BUY
Exercise of conversion of derivative security
$32,023 $1.81 p/Share
17,692 Added 1.41%
1,232,697 Common Shares
Jun 22 2017
SELL
Open market or private sale
$166,380 $15.37 p/Share
10,825 Reduced 0.88%
1,215,005 Common Shares
Jun 22 2017
BUY
Exercise of conversion of derivative security
$19,593 $1.81 p/Share
10,825 Added 0.88%
1,225,830 Common Shares
Jun 21 2017
SELL
Open market or private sale
$173,902 $15.02 p/Share
11,578 Reduced 0.94%
1,215,005 Common Shares
Jun 21 2017
BUY
Exercise of conversion of derivative security
$20,956 $1.81 p/Share
11,578 Added 0.91%
1,266,583 Common Shares
Jun 20 2017
SELL
Open market or private sale
$48,780 $15.0 p/Share
3,252 Reduced 0.27%
1,215,005 Common Shares
Jun 20 2017
BUY
Exercise of conversion of derivative security
$5,886 $1.81 p/Share
3,252 Added 0.27%
1,218,257 Common Shares
Jun 19 2017
SELL
Open market or private sale
$230,880 $15.0 p/Share
15,392 Reduced 1.25%
1,215,005 Common Shares
Jun 19 2017
BUY
Exercise of conversion of derivative security
$27,860 $1.81 p/Share
15,392 Added 1.24%
1,230,397 Common Shares
Jun 09 2017
SELL
Open market or private sale
$16,588 $15.08 p/Share
1,100 Reduced 0.09%
1,215,005 Common Shares
Jun 09 2017
BUY
Exercise of conversion of derivative security
$1,991 $1.81 p/Share
1,100 Added 0.09%
1,216,105 Common Shares
Jun 08 2017
SELL
Open market or private sale
$63,045 $15.0 p/Share
4,203 Reduced 0.34%
1,215,005 Common Shares
Jun 08 2017
BUY
Exercise of conversion of derivative security
$7,607 $1.81 p/Share
4,203 Added 0.34%
1,219,208 Common Shares
RN

Rodger Novak

President
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP